2003Q-0559 - Qualified Health Claim (QHC): Monounsaturated fatty acids and reduced risk of coronary heart disease

  


  

  


  

  


  

  


  

  
FDA Comment Number : 
  

  
EC1
  



  

  

  



  

  
Submitter : 
  

  
Mr. John Profaci
  

  
Date & Time: 
  

  
02/09/2004 04:02:48
  



  

  
Organization : 
  

  
Colavita USA, LLC
  



  

  
Category : 
  

  
Food Industry
  



  

  
Issue Areas/Comments 
  


  

  



  

  
GENERAL
  


  

  



  

  
GENERAL
  


  

  



  

  
 

I'm writing to express my support of Docket # 2003Q-0559, Health Claim

Petition: Monounsaturated Fatty Acids from Olive Oil and Coronary Heart Disease.



FDA has long recognized the potential role of monounsaturated fatty acids in managing the risk of coronary heart disease, even citing it in 1993 when authorizing the health claim on dietary saturated fat and cholesterol and heart disease. Since then, considerable information has further demonstrated that monounsaturated fatty acids can lower total- and low-density lipoprotein cholesterol when consumed as part of a diet low in saturated fat.  Furthermore, these studies demonstrate that monounsaturated fatty acids do not increase blood triglycerides or decrease HDL and high carbohydrate diets often do.  



Given the multitude of studies citing the benefits of monounsaturated fatty acids and olive oil that were submitted with the petition, I urge the Food and Drug Administration to authorize this claim.



Very truly yours,





John J. Profaci

President